LAURA ROSS: Open Payments
NPI 1538417142 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 4 payments from 4 companies in 2025. Trend: 2023 $245 · 2024 $0 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $97 |
| ABBVIE INC. | 1 | $73 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Auvelity, VRAYLAR, REXULTI, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
